Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
4,988
-65
-1% -$22.3K 0.04% 269
2026
Q1
$1.78M Sell
5,053
-6,745
-57% -$2.4M 0.06% 231
2025
Q4
$3.86M Sell
11,798
-1,824
-13% -$579K 0.13% 111
2025
Q3
$3.84M Buy
13,622
+8,914
+189% +$2.59M 0.15% 108
2025
Q2
$1.31M Sell
4,708
-57
-1% -$16.1K 0.06% 270
2025
Q1
$1.48M Sell
4,765
-352
-7% -$104K 0.06% 245
2024
Q4
$1.33M Sell
5,117
-7,141
-58% -$2.12M 0.07% 241
2024
Q3
$3.95M Buy
12,258
+8,237
+205% +$2.69M 0.01% 1057
2024
Q2
$1.26M Buy
4,021
+1,394
+53% +$410K ﹤0.01% 1870
2024
Q1
$747K Buy
+2,627
New +$769K ﹤0.01% 2224
2023
Q3
Sell
-12,505
Closed -$3.12M 3895
2023
Q2
$2.78M Buy
+12,505
New +$2.9M 0.09% 210

Other funds holding AMGN

GTS Securities's AMGN Position: Q2 2026 in Review

GTS Securities reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $22.3K and leaving 4,988 shares worth $1.81M. The position accounts for 0.04% of the portfolio, ranked #269.

GTS Securities first reported a position in AMGN in Q2 2023 and has held it in 11 quarters since. The position peaked at $3.95M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GTS Securities held 4,988 shares of Amgen worth $1.81M as of Q2 2026.
  • GTS Securities sold 65 Amgen shares in Q2 2026, an estimated $22.3K.
  • Amgen made up 0.04% of GTS Securities's portfolio in Q2 2026, its #269 holding.
  • GTS Securities first reported a position in Amgen in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's Amgen position peaked at $3.95M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.